| The legal status of medical marijuana. | |
| | |
MedLine Citation:
|
PMID: 17062830 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To review the legal status of medical marijuana in the US. DATA SOURCES: Relevant publications were located using LexisNexis (1982-October 2006), WestLaw (1996-October 2006), BNA Health Law Reporter (1996-October 2006), MEDLINE (1996-October 2006), EMBASE (1980-October 2006), International Pharmaceutical Abstracts (1970-October 2006), and an Internet search targeting government sites using the key words medical marijuana. STUDY SELECTION AND DATA EXTRACTION: Federal and state medical marijuana laws were examined. Relevant cannabinoid-based drug products were reviewed. Federal and State Supreme Court and Appeal level cases involving medical marijuana were evaluated. DATA SYNTHESIS: Marijuana is regulated as a Schedule I controlled substance and its use is prohibited under federal law. Dronabinol and nabilone are synthetic cannabinoids approved by the Food and Drug Administration and Sativex is a cannabis-based extract being evaluated in Phase III trials. The federal government sponsors a single patient compassionate use Investigational New Drug Application program providing medical marijuana for a small number of patients. Eleven states permit marijuana use for medical purposes and one state provides a defense of medical necessity. Employers do not have to provide workplace accommodations for employees using medical marijuana and can terminate them at will. Healthcare providers have First Amendment constitutional protections that allow them to discuss marijuana with patients. CONCLUSIONS: Until the Supreme Court rules directly on the constitutionality of state medical marijuana laws, a conflict remains. Marijuana use remains illegal under federal law and states assume their medical marijuana laws to be constitutional. |
| | |
Authors:
|
Matthew J Seamon |
Publication Detail:
|
Type: Journal Article; Review Date: 2006-10-24 |
Journal Detail:
|
Title: The Annals of pharmacotherapy Volume: 40 ISSN: 1542-6270 ISO Abbreviation: Ann Pharmacother Publication Date: 2006 Dec |
Date Detail:
|
Created Date: 2006-12-13 Completed Date: 2007-01-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9203131 Medline TA: Ann Pharmacother Country: United States |
Other Details:
|
Languages: eng Pagination: 2211-5 Citation Subset: IM |
Affiliation:
|
College of Pharmacy, Nova Southeastern University, 3200 S. University Dr., Fort Lauderdale, FL 33328-2018, USA. mseamon@nova.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Drug and Narcotic Control
/
legislation & jurisprudence*,
methods Federal Government* Humans Marijuana Smoking / legislation & jurisprudence* State Government* United States |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Increase in rapid defibrillation programmes after publication of guidelines.
Next Document: Diminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura...